Eli Lilly’s experimental obesity drug, retatrutide, has shown impressive results in mid-stage clinical trials, with patients experiencing up to 24% weight loss after almost a year, the highest reduction seen in the field. The…
Continue Reading
Shannon West, Chief Product Officer for Datavant
The healthcare industry is facing immense pressure to provide patients with seamless and compliant access to their medical records. Despite recent regulations that discourage information blocking and promote…
Continue Reading
Germany introduced prescription-based mobile health (mHealth) apps in October 2020, becoming the first country to offer them fully reimbursed by health insurance. These regulated apps, known as DiGAs, undergo a rigorous approval process similar…
Continue Reading
The continued maturation of decentralized clinical trials (DCTs) has given researchers the ability to securely collect real-world data on patients as they go about their daily routines. This broader access provides us with new,…
Continue Reading
What You Should Know:
Walgreens and Freenome form a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer. Walgreens will combine its national footprint, patient insights, compliant recruitment technology…
Continue Reading
Recent scientific advances and the introduction of sophisticated clinical research platforms have enabled medical researchers and healthcare practitioners to cater to the evolving challenges within the pharmaceutical industry and deliver improved quality of care…
Continue Reading
When regulators speak, we listen.
Naturally risk-averse industries like the life sciences need health authority acceptance before trying new approaches and especially before committing to wholesale operational change, even if the outcome has great potential….
One of the fastest-growing frontiers of healthcare is Digital Therapeutics (DTx), which utilizes clinically tested software to prevent, treat, and manage a growing range of medical conditions. During Covid-19, governing agencies loosened regulatory requirements…
Continue Reading
Researchers at NYU Langone Health developed NYUTron, a large language model (LLM) that predicts a patient’s risk of readmission and other clinical outcomes. The code for NYUTron is available on GitHub, allowing other healthcare…
Continue Reading
Diagnostics company Nutromics has raised A$11 million ($7 million) ahead of its Series A funding round later this year.WHAT IT’S FOR
The company has been raising funds for the imminent commercialisation of its continuous diagnostic…
